Related Experiment Videos
Influenza vaccine: issues and opportunities
K M Neuzil1, M R Griffin, W Schaffner
1Division of Infectious Diseases, University of Washington School of Medicine,Seattle,USA.
Infectious Disease Clinics of North America
|April 17, 2001
Summary
Recent advancements in influenza management include rapid diagnostic tests for targeted antiviral therapy and newer neuraminidase inhibitor treatments. Annual inactivated influenza vaccines are recommended for older adults, at-risk individuals, and pregnant women.
Area of Science:
- Public Health
- Infectious Diseases
- Vaccinology
Background:
- Influenza remains a significant public health concern, necessitating improved diagnostic, therapeutic, and preventive strategies.
- Traditional influenza treatments and diagnostics have limitations that newer developments aim to address.
Purpose of the Study:
- To review recent advancements in influenza diagnosis, treatment, and prevention.
- To highlight the benefits and considerations of new influenza management tools.
Main Methods:
- Review of recent developments in influenza diagnostics.
- Analysis of novel antiviral therapies, specifically neuraminidase inhibitors.
- Examination of current recommendations for inactivated influenza vaccination.
Main Results:
- Rapid diagnostic tests aid in appropriate antiviral selection and reduce unnecessary antibiotic use.
- Neuraminidase inhibitors offer effective influenza treatment with a potentially improved side effect profile compared to older drugs.
- Annual inactivated influenza vaccination is recommended for individuals aged 50+, at-risk younger populations, and pregnant women.
Conclusions:
- New diagnostic and therapeutic options enhance influenza patient care.
- Updated vaccination guidelines aim to protect vulnerable populations from severe influenza complications.
- Integrated strategies utilizing diagnostics, therapeutics, and vaccines are crucial for influenza control.